BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 36385449)

  • 1. Neuropsychiatric aspects of long COVID: A comprehensive review.
    Kubota T; Kuroda N; Sone D
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):84-93. PubMed ID: 36385449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
    Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
    J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sleep disorders in post-COVID syndrome - a problem of psychiatry or neurology?].
    Kotova OV; Medvedev VE; Poluektov MG; Belyaev AA; Akarachkova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(5. Vyp. 2):23-28. PubMed ID: 35759562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms.
    Calabria M; García-Sánchez C; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Estévez García MDC; Belvís R; Morollón N; Vera Igual J; Mur I; Pomar V; Domingo P
    J Neurol; 2022 Aug; 269(8):3990-3999. PubMed ID: 35488918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term central nervous system (CNS) consequences of COVID-19 in children.
    Howe de la Torre S; Parlatini V; Cortese S
    Expert Rev Neurother; 2023; 23(8):703-720. PubMed ID: 37545414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19.
    Liu EN; Yang JH; Patel L; Arora J; Gooding A; Ellis R; Graves JS
    J Neurol; 2023 Oct; 270(10):4661-4672. PubMed ID: 37493802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections.
    Woo MS; Mayer C; Brehm TT; Andersen G; Weigel A; Löwe B; Lohse AW; Addo MM; Gerloff C; Knobloch JKM; Schulze Zur Wiesch J; Friese MA
    Brain Commun; 2023; 5(2):fcad092. PubMed ID: 37038497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsychiatric Aspects of COVID-19 - A Narrative Overview].
    Rittmannsberger H; Barth M; Malik P; Yazdi K
    Fortschr Neurol Psychiatr; 2022 Mar; 90(3):108-120. PubMed ID: 34341978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic neuropsychiatric symptoms in novel coronavirus disease 2019 (COVID-19) patients: A qualitative review.
    Smith CJ; Renshaw P; Yurgelun-Todd D; Sheth C
    Front Public Health; 2022; 10():772335. PubMed ID: 36033820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric Complications of COVID-19.
    Nakamura ZM; Nash RP; Laughon SL; Rosenstein DL
    Curr Psychiatry Rep; 2021 Mar; 23(5):25. PubMed ID: 33725218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropsychiatric aspects of long COVID].
    Everaerd DS; Biere-Rafi S
    Tijdschr Psychiatr; 2023; 65(6):347-353. PubMed ID: 37434573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric and neurological complications of long COVID.
    Zawilska JB; Kuczyńska K
    J Psychiatr Res; 2022 Dec; 156():349-360. PubMed ID: 36326545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-COVID syndrome-Focus fatigue].
    Hellwig S; Domschke K
    Nervenarzt; 2022 Aug; 93(8):788-796. PubMed ID: 35606656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychiatric dimensions of post-COVID-19 condition : an overview].
    Berney A; Marillier G
    Rev Med Suisse; 2023 May; 19(827):975-978. PubMed ID: 37195113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).
    Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Katsantoni E; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Ferentinos P; Smyrnis N; Rizos E
    Exp Ther Med; 2022 Nov; 24(5):705. PubMed ID: 36324612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Molecular Biomarker-Based Triage Approach for Targeted Treatment of Post-COVID-19 Syndrome Patients with Persistent Neurological or Neuropsychiatric Symptoms.
    Guest PC; Neyazi A; Braun-Dullaeus RC; Müller P; Schreiber J; Haghikia A; Vasilevska V; Steiner J
    Adv Exp Med Biol; 2023; 1412():97-115. PubMed ID: 37378763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.
    Troyer EA; Kohn JN; Hong S
    Brain Behav Immun; 2020 Jul; 87():34-39. PubMed ID: 32298803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.
    Schwartz RA; Suskind RM
    Epidemiol Infect; 2023 Dec; 152():e34. PubMed ID: 38097277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.